- Home
- NUVB vs RNG Comparison
NUVB vs RNG Comparison
Compare NUVB & RNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NUVB | RNG |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.4B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | NUVB | RNG |
|---|---|---|
| Price | $8.62 | $29.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 14 |
| Target Price | $9.63 | ★ $31.23 |
| AVG Volume (30 Days) | ★ 10.2M | 1.3M |
| Earning Date | 11-03-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | $26,748,000.00 | ★ $2,485,621,000.00 |
| Revenue This Year | $283.17 | $5.73 |
| Revenue Next Year | $340.98 | $4.49 |
| P/E Ratio | ★ N/A | $210.78 |
| Revenue Growth | ★ 1137.19 | 5.45 |
| 52 Week Low | $1.54 | $20.59 |
| 52 Week High | $8.70 | $42.19 |
Technical Indicators
Market Signals| Indicator | NUVB | RNG |
|---|---|---|
| Relative Strength Index (RSI) | 76.08 | 61.04 |
| Support Level | $7.46 | $28.72 |
| Resistance Level | $8.24 | $29.80 |
| Average True Range (ATR) | 0.62 | 0.86 |
| MACD | 0.13 | 0.31 |
| Stochastic Oscillator | 97.20 | 90.06 |
Price Performance
Historical ComparisonAbout NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.